Funds development of the first FDA-authorized agentic AI technology providing 24/7 specialty cardiovascular care. Research includes creating patient-facing AI agents, supervisory safety components, and integration with wearable monitors and digital health records. The program aims to improve heart failure and heart attack management by deploying AI clinician-extenders to enhance care access and reduce costs.
Eligible applicants include private and public entities with technical and operational expertise encouraged to form teams and submit research proposals.
